Aging is not a single mechanism failure — it is the convergent expression of telomere shortening, mitochondrial dysfunction, loss of proteostasis, increased inflammation, stem cell exhaustion, and altered intercellular communication. No single peptide addresses all hallmarks simultaneously. Multi-compound research protocols target several mechanisms in parallel, allowing researchers to study additive, synergistic, or antagonistic interactions between longevity pathways.
| Compound | Primary Target | Mechanism |
|---|---|---|
| Epitalon (10 mg) | Telomere/Pineal | Telomerase activation, melatonin regulation |
| NAD+ (500 mg) | Sirtuin/NAD metabolism | Sirtuin 1/3 activation, DNA repair, metabolic regulation |
| GHK-Cu (2 mg) | Tissue remodelling | Collagen synthesis, antioxidant, gene expression |
| BPC-157 (500 mcg) | Systemic repair | GH receptor upregulation, angiogenesis, NO modulation |
| SS-31 (5 mg) | Mitochondria | Cardiolipin stabilisation, ETC efficiency, ATP production |
| MOTS-c (15 mg) | Metabolic flexibility | AMPK activation, insulin sensitisation, exercise mimetic |
Epitalon operates at the nuclear level (telomerase/telomere elongation) while SS-31 operates at the mitochondrial inner membrane (cardiolipin/ETC). These two mechanisms are independent and potentially synergistic: both address fundamental drivers of cellular aging at different subcellular locations. Animal studies of both compounds independently show improvements in lifespan and age-related decline markers.
NAD+ replenishment activates sirtuins (SIRT1, SIRT3) which regulate mitochondrial biogenesis, deacetylate and activate key metabolic enzymes, and coordinate DNA repair. MOTS-c activates AMPK, which has both overlapping and distinct effects on mitochondrial function and metabolic flexibility. Together they represent a comprehensive approach to the metabolic dimensions of aging.
GHK-Cu (copper tripeptide) upregulates over 4,000 human genes involved in collagen synthesis, antioxidant defence, and skin/connective tissue maintenance. BPC-157 promotes angiogenesis, modulates the NO system, and accelerates repair of gastrointestinal, musculoskeletal, and neural tissues. Combined, they address the structural tissue degradation aspect of aging.
Most longevity peptide research protocols follow a cyclical pattern: 20-day on / 10-day off for Epitalon (following Khavinson's original telomerase research cycles), with continuous protocols for metabolic peptides (NAD+, MOTS-c) and injury-context protocols for BPC-157 and TB-500. All compounds are available from QSC with batch-level Janoshik COA.
This page is for educational and research purposes only. All products sold by QSC are labelled for research use only and are not intended for human consumption. Nothing on this page constitutes medical advice.